Oklahoma City, OK


Inoveon integrates the advances of the internet with a patented Digital Disease Detection and Tracking (3DT) Service™ to provide the next generation of disease management. The medical services company provides digital iScan services to detect stage and monitor diabetic retinopathy in the primary diabetes care setting.


Inoveon was acquired by the German-headquartered company, IFA Systems. 


(Click to return to the previous page)

The Oklahoma Life Science Fund  |  T 918.584.0440  |  |  © 2013 by The Oklahoma Life Science Fund

  • facebook
  • LinkedIn Square
This site was designed with the
website builder. Create your website today.
Start Now